Inventor · disambiguated record
Jean-Luc Fauchere
Also filed as: FAUCHERE JEAN-LUC
10 granted patents·3 pending applications·73 citations·filing 1992–2003
88Inventor score
Top patents by PatentIndex Score
13 records- 0188US6245916B1Aminotriazole compoundsADIR·Filed 2000·Granted Jun 12, 2001·34 cites·13 claims
- 0275US6596749B2Aminotriazole compoundsSERVIER LAB·Filed 2001·Granted Jul 22, 2003·8 cites·13 claims
- 0350US5569647AAngiopeptin cyclopeptide compoundsADIR·Filed 1995·Granted Oct 29, 1996·9 cites·3 claims
- 0445US5409899APseudopeptide compounds having anti-inflammatory activityADIR·Filed 1993·Granted Apr 25, 1995·6 cites·3 claims
- 0540US5786330APeptide compounds which are therapeutically active in the cascade of blood coagulation, process for preparing them and pharmaceutical compositions containing themADIR·Filed 1994·Granted Jul 28, 1998·3 cites·6 claims
- 0638US2004029875A1Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing sameFiled 2001·Application pending·0 cites
- 0738US2003199530A1New compounds derived from quinazolineFiled 2003·Application pending·0 cites
- 0837US5317014APeptides and pseudopeptides derived from tachykininADIR·Filed 1992·Granted May 31, 1994·4 cites·9 claims
- 0937US2005106707A1Automatic apparatus for synthesis of small organic molecules and synthesis method using sameFiled 2002·Application pending·0 cites
- 1035US5561113ANew pseudopeptide compounds of neurokininsADIR·Filed 1995·Granted Oct 1, 1996·3 cites·7 claims
- 1134US5565426APeptide compounds active in cell adhesion processesADIR·Filed 1994·Granted Oct 15, 1996·2 cites·12 claims
- 1233US5708016APseudopeptides derived from neurokininsADIR·Filed 1997·Granted Jan 13, 1998·2 cites·9 claims
- 1331US5371071APeptide and pseudopeptide compounds which are therapeutically active in the blood coagulation cascadeADIR·Filed 1993·Granted Dec 6, 1994·2 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Jean-Luc Fauchere files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →